We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Upholds FMT Enforcement Discretion in New Guidance
FDA Upholds FMT Enforcement Discretion in New Guidance
July 31, 2013
The FDA has issued guidance solidifying a previous statement that it will use enforcement discretion regarding fecal microbiota transplants (FMT) for clinical use to treat Clostridium difficile (C. difficile).